Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Endovia Health Sciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +5 vs. Q1 2023
- Shares held
- 2.62M
- +518.1K (+24.6%) vs. Q1 2023
- Total value
- $2.93M
- −$514.8K (−14.9%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 0
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,257,887 | $1.41M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 223,120 | $249.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 203,845 | $228.3K | 0.00% | +141,537+227.2% | Added |
| Commonwealth Equity Services, LLC | 128,250 | $144.0K | 0.00% | +128,250 | New |
| Bridgeway Capital Management, LLC | 127,300 | $142.6K | 0.00% | +25,000+24.4% | Added |
| Citadel Advisors LLC | 119,717 | $134.1K | 0.00% | +33,756+39.3% | Added |
| BlackRock Inc. | 89,086 | $99.8K | 0.00% | +13,880+18.5% | Added |
| State Street Corp | 70,000 | $78.4K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 68,120 | $76.0K | 0.00% | +43,856+180.7% | Added |
| Northern Trust Corp | 49,754 | $55.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 48,400 | $54.0K | 0.00% | +48,400 | New |
| Two Sigma Securities, LLC | 36,094 | $40.4K | 0.00% | +36,094 | New |
| Parsons Capital Management Inc | 33,249 | $37.2K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 32,500 | $36.0K | 0.05% | +32,500 | New |
| RSM US Wealth Management LLC | 26,000 | $29.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 22,821 | $25.6K | 0.00% | +22,821 | New |
| Simplex Trading, LLC | 23,212 | $25.0K | 0.00% | +8,758+60.6% | Added |
| Charles Schwab Investment Management Inc | 20,360 | $22.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14,200 | $15.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,709 | $13.1K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 10,000 | $11.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,931 | $3.28K | 0.00% | −9,005−75.4% | Reduced |
| UBS Group AG | 900 | $1.01K | 0.00% | −5,230−85.3% | Reduced |
| Wells Fargo & Company | 213 | $239 | 0.00% | +13+6.5% | Added |
| FMR LLC | 5 | $6 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 435 | $0 | 0.00% | −2,565−85.5% | Reduced |